{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:14:27Z","timestamp":1760044467750},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.tube.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T09:20:52Z","timestamp":1429262452000},"page":"490-496","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Moxifloxacin plus standard first-line therapy in the treatment of\u00a0pulmonary tuberculosis: A meta-analysis"],"prefix":"10.1016","volume":"95","author":[{"given":"Zhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Sheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2015.03.014_bib1","unstructured":"2004. World health report 2004: changing history. WHO. Geneva, Switzerland. http:\/\/www.who.int\/whr\/2004\/en\/report04_en.pdf."},{"key":"10.1016\/j.tube.2015.03.014_bib2","unstructured":"2007. Global tuberculosis control\u2014 surveillance, planning, financing. WHO. Geneva, Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/2007\/download_centre\/en\/index.html."},{"key":"10.1016\/j.tube.2015.03.014_bib3","first-page":"437","article-title":"Low access to a highly effective therapy: a challenge for international tuberculosis control","volume":"80","author":"Dye","year":"2002","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tube.2015.03.014_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI34614","article-title":"Confronting the scientific obstacles to global control of tuberculosis","volume":"118","author":"Young","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2015.03.014_bib5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1592\/phco.29.12.1468","article-title":"Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the society of infectious diseases pharmacists","volume":"29","author":"Hall","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tube.2015.03.014_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/13543784.2013.801958","article-title":"PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis","volume":"22","author":"Dawson","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.tube.2015.03.014_bib7","series-title":"Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.tube.2015.03.014_bib8","series-title":"Global tuberculosis control 2008-surveillance, planning, financing","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.tube.2015.03.014_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.5588\/ijtld.12.0277","article-title":"New drugs for the treatment of tuberculosis: hope and reality","volume":"16","author":"Grosset","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.03.014_bib10","series-title":"Cochrane collaboration handbook for systematic reviews of interventions version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1016\/j.tube.2015.03.014_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/ajrccm\/147.4.1062","article-title":"Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months","volume":"147","author":"Mitchison","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2015.03.014_bib12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"Bmj"},{"key":"10.1016\/j.tube.2015.03.014_bib13","first-page":"65","article-title":"Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis","volume":"14","author":"Wang","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.03.014_bib14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"Conde","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2015.03.014_bib15","first-page":"128","article-title":"A\u00a0phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2015.03.014_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2015.03.014_bib17","unstructured":"Jawahar MS, Banurekha VV, Paramasivan CN, Rahman F, Ramachandran R, Venkatesan P, et\u00a0al. Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients. PLoS ONE;8(7):e67030. N Engl J Med 2014;371:1577\u20131587."},{"key":"10.1016\/j.tube.2015.03.014_bib18","unstructured":"Gillespie SH, Crook AM, McHugh TD, Mendel CM, Meredith SK, Murray SR, et\u00a0al. Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis."},{"key":"10.1016\/j.tube.2015.03.014_bib19","first-page":"CD004795","article-title":"Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)","volume":"6","author":"Ziganshina","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tube.2015.03.014_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/520275","volume":"26","author":"el-Sadr","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214206664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979214206664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T12:30:22Z","timestamp":1537705822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979214206664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1472979214206664"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2015.03.014","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moxifloxacin plus standard first-line therapy in the treatment of\u00a0pulmonary tuberculosis: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}